Concentra Group Parent (CON) vs Veracyte (VCYT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Concentra Group Parent (CON) has outperformed Veracyte (VCYT) over the past year, gaining 73.7% versus a gain of 24.7%. Concentra Group Parent is the larger company by market cap ($4.64 billion vs $3.47 billion), about 1.3 times the size. On valuation, Concentra Group Parent trades at a lower forward P/E (19.8x vs 22.1x for Veracyte).
Concentra Group Parent pays a dividend yielding 0.69%, while Veracyte does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CON | VCYT |
|---|---|---|
| Share price | $36.40 | $43.16 |
| Market cap | $4.64B | $3.47B |
| 1-day change | 0.00% | -3.34% |
| YTD return | +84.96% | +2.52% |
| 1-year return | +73.66% | +24.70% |
| 5-year return | — | -4.43% |
| P/E ratio (TTM) | 23.48 | 30.83 |
| Forward P/E | 19.77 | 22.13 |
| EPS (TTM) | $1.55 | $1.40 |
| Dividend yield | 0.69% | 0.00% |
| Annual dividend | $0.25 | $0.00 |
| Revenue (latest FY) | $2.16B | — |
| Revenue growth (YoY) | +13.85% | — |
| Net income (latest FY) | $166.41M | — |
| Gross margin | 28.34% | — |
| Operating margin | 15.44% | — |
| Net margin | 7.69% | — |
| 52-week high | $36.83 | $60.91 |
| 52-week low | $18.55 | $29.46 |
| Distance from 52-week high | -1.17% | -29.14% |
| Analyst consensus | none | buy |
| Avg. price target upside | +12.64% | +35.36% |
| Average volume | 912.48K | 1.35M |
| Shares outstanding | 127.52M | 80.39M |
| Employees | 9,967 | 755 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CON has outperformed VCYT by 49.0 percentage points over the past year.
- Veracyte trades at a higher earnings multiple (30.8x vs 23.5x trailing P/E).
About Concentra Group Parent
CON stock →Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.
Health Care · Medical Specialities · 9,967 employees
About Veracyte
VCYT stock →Veracyte, Inc. operates as a diagnostics company in the United States and internationally.
Health Care · Medical Specialities · 755 employees
CON vs VCYT FAQ
Which is bigger, Concentra Group Parent or Veracyte?
Concentra Group Parent (CON) is larger, with a market capitalization of $4.64B compared with $3.47B for Veracyte (VCYT).
Which stock has performed better over the past year, CON or VCYT?
CON returned +73.66% over the past 12 months, compared with +24.70% for VCYT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CON or VCYT?
CON has the lower trailing P/E at 23.5, versus 30.8 for VCYT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Concentra Group Parent or Veracyte?
Concentra Group Parent pays a dividend yielding 0.69%, while Veracyte does not currently pay a regular dividend.
Are Concentra Group Parent and Veracyte in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.